It’s a new age for science as the US Food and Drug Administration gave its approval for scientists to conduct genetic manipulation in an effort to combat leukemia. This could potentially lead to a cure that does not require extensive chemotherapy, but it is also a new frontier. Gene-editing technology has existed for decades but it wasn’t until recently that it became much cheaper and more accessible.
For all intents and purposes, genetic manipulation can be used for practically any end for as long as it has something to do with organic materials. In the case of humans, the tool called CRISPR can allow scientists to finally start cutting away or adding specific genetic materials that can change a person’s physiology. With regards to leukemia, scientists want to alter cells to make them more resistant to the disease, the New York Times reports.
By creating tougher and more aggressive cells to fight leukemia or other forms of cancer, patients would theoretically never have to take medicine of any kind ever again. They would have a living drug in their system, which would make them practically immune to fatal diseases.
Naturally, there are plenty of concerns when it comes to genetic manipulation that makes getting approval for tests incredibly difficult. The company that finally got approval is Novartis and one of the company’s biggest achievements is 12-year-old Emily Whitehead who is now free of leukemia thanks to the revolutionary treatment.
When speaking to the FDA panel before approval was granted, Emily’s father, Tom Whitehead made a passionate case in favor of the treatment. The premise was simple; approve the treatment and thousands will be saved, Futurism reports.
“I hope that someday all of you on the advisory committee can tell your families for generations that you were part of the process that ended the use of toxic treatments like chemotherapy and radiation as standard treatment, and turned blood cancers into a treatable disease that even after relapse most people survive.”


US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



